TNNT2 and peripheral arterial disease: Otaki et al. [22] similarly observed in 208 newly diagnosed PAD patients that elevated hs-cTnT independently predicted MACE and all-cause death, even after adjustment for established risk factors and biomarkers such as B-type natriuretic peptide and heart-type fatty acid-binding protein.